▣ Ingredient: 1 mL contains    

 ㆍActive Ingredient: 

    - Lidocaine Hydrochloride(USP) ............... 20 mg       

    - Epinephrine(USP) ................................ 0.01 mg    

  ㆍExcipient       

    - E.D.T.A ................................................. 0.25 mg       

    - Sodium Chloride .................................. 7.83 mg       

    - Methylparabene ..................................... 1.2 mg       

    - Injectable Water   

▣ Description

- Colorless and transparent solution, free of visible particles, sterile and isotonic. 

▣ Indication     

- Local Anesthetic by infiltration and/or nerve blockage for use in dentistry and stomatology.     

- For use in pediatric patients, adults and elderly people.     

- For all kind of dental interventions which require a long anesthetic effect.     

- Ideal choice for procedures that require the haemostatic property of Epinephrine.        

▣ Usage and Dose     

- Route of administration by parenteral local infiltration and/or proximal block.     

- The dose depends on the technique, the area to be anesthetized and overall health of the patient; the use of the lowest effective dose should be encouraged.     

- Adult and pediatric maximum dose : 4.4 mg/Kg body weight. No more than 300 mg should be used per session, in a healthy patient.   

▣ Precautions for use     

- Do not use for the following patient(contraindications)       

   1) In patients who have hypersensitivity to local anesthetics of the same group of Amides.       

   2) Serious liver disorders : Cirrhosis, Porphyria.       

   3) Patients with unsupervised epilepsy treatment.       

   4) Patients with hyperthyroidism       

   5) Cardiovascular affections : Arrhythmias, hypertension and cardiac pathology.      

- General cautions        

   1) The patients under the effect of the anesthesia should postpone the food ingestion until the sensitivity of lips, cheeks and tongue is recovered.       

   2) In pediatric, elderly and patients with nutrition deficiencies, the dose must be decreased.       

   3) Disorders in atrioventricular conduction without a permanent electrosystolic treatment.       

   4) Use extreme caution in patients with liver diseases due to metabolism by the liver of the amide-type anesthetics.       

   5) To minimize risk of intravascular injection aspiration is recommended before injection.       

   6) When using any type of local anesthetic oxygen equipment and resuscitation drugs should be available for immediate use.       

   7) Products containing Sodium Metabisulfite can cause allergic reactions including anaphylactic symptoms and asthmatic episodes in certain susceptible people. This sensitivity is seen more frequently in asthmatic people.        

   8) Injection into swollen or infected area should be avoided because it can change the pH and thus modify the anesthetic effect. 

▣ Storage

- Store at room temperature 15℃~30℃(59℉~86℉) 

▣ Packaging unit

- 1.8 mL x 50 cartridge per box